Lower-Dose Treatments for Early-Stage Hodgkin Lymphoma Do Not Compromise Results
In a phase III trial, people with early-stage, low-risk Hodgkin lymphoma who received lower doses of chemotherapy and/or radiotherapy had clinical outcomes that were no worse than those of people who received higher doses.
Emerging Therapies in Non-Hodgkin Lymphoma
Research into the causes, prevention, and treatment of non-Hodgkin lymphoma is being done in many medical centers throughout the world.
NCCN Updates NHL Guidelines
Two recent FDA approvals have prompted the National Comprehensive Cancer Network to update the NCCN Clinical Practice Guidelines in Oncology™ for Non-Hodgkin’s Lymphomas treatment options for selected people with two types of non-Hodgkin’s Lymphomas.
What Happens After Treatment for Non-Hodgkin Lymphoma?
Completing treatment can be both stressful and exciting. You will be relieved to finish treatment, yet it is hard not to worry about cancer coming back. This is a very common concern among those who have had cancer.
Coping with Blood Cancers
Cure rates and remission periods for adults with leukemia, lymphoma, myeloma, myelodysplastic syndromes, and other blood cancers are greatly improved because of new drugs, new uses for existing drugs, and improvements in radiation therapy and stem cell transplantation techniques. Research to improve health outcomes for more people with blood cancers is ongoing. Physicians are working to tailor therapies to decrease side effects, as well as long-term and late effects.
Hodgkin Lymphoma Survivors Have Increased Risk of Stroke and Transient Ischemic Attack
People treated for Hodgkin lymphoma with radiation therapy have a substantially higher risk of stroke, according to a new study published in the Journal of the National Cancer Institute.
Leukemia & Lymphoma Society Fighting Blood Cancers
by Peter West
More than 138,000 Americans will be diagnosed with leukemia, lymphoma, and myeloma this year. For many, a trusted source of information and support will be The Leukemia & Lymphoma Society.
Helping Survivors Thrive after Marrow and Cord Blood Transplants
by Elizabeth A. Murphy, EdD, RN
Advances in transplant science have improved outcomes and have made transplant a viable treatment option for more people and a wider range of diseases.